Locoregional treatment of primary breast cancer: consensus recommendations from an International Expert Panel.
about
Current status of ultrasound-guided surgery in the treatment of breast cancerNipple areola complex sparing mastectomyBreast reconstruction following prophylactic or therapeutic mastectomy for breast cancer: Recommendations from an evidence-based provincial guidelineThree-dimensional quantitative ultrasound for detecting lymph node metastases.Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer.Ultrasound-guided breast-sparing surgery to improve cosmetic outcomes and quality of life. A prospective multicentre randomised controlled clinical trial comparing ultrasound-guided surgery to traditional palpation-guided surgery (COBALT trial).Understanding the factors associated with the surgical management of early breast cancer.Health-related quality of life in survivors of stage I-II breast cancer: randomized trial of post-operative conventional radiotherapy and hypofractionated tomotherapy.Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Utilization of neoadjuvant chemotherapy varies in the treatment of women with invasive breast cancer.Optimal sequence of implied modalities in the adjuvant setting of breast cancer treatment: an update on issues to considerAssessment of knowledge of cancer and lymphoedema among breast cancer survivors.Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trialIntraoperative Ultrasound Guidance in Breast-Conserving Surgery Improves Cosmetic Outcomes and Patient Satisfaction: Results of a Multicenter Randomized Controlled Trial (COBALT)Evaluation of surgical outcomes following oncoplastic breast surgery in early breast cancer and comparison with conventional breast conservation surgery.Long-term outcome of neoadjuvant systemic therapy for locally advanced breast cancer in routine clinical practice.Surgical margin reporting in breast conserving surgery: Does compliance with guidelines affect re-excision and mastectomy rates?Tissue-simulating phantoms for assessing potential near-infrared fluorescence imaging applications in breast cancer surgery.Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer.Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343CYP19 genetic polymorphism haplotype AASA is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer.Intraoperative Ultrasound in the Treatment of Breast CancerInterdisciplinary GoR level III Guidelines for the Diagnosis, Therapy and Follow-up Care of Breast Cancer: Short version - AWMF Registry No.: 032-045OL AWMF-Register-Nummer: 032-045OL - Kurzversion 3.0, Juli 2012.Neoadjuvant systemic treatment of breast cancer.The role of magnetic resonance imaging in early breast cancer.Predictive biomarkers in breast cancer: their value in neoadjuvant chemotherapy.Breakthroughs in research and treatment of early breast cancer: an overview of the last three decades.What is a clear margin in breast conserving cancer surgery?Utility of neoadjuvant chemotherapy in the treatment of operable breast cancer.Management of locally advanced breast cancer-perspectives and future directions.The importance of surgical margins in breast cancer.Trends in breast cancer surgery at Brazil's public health system.Oncological Outcomes and Complications After Volume Replacement Oncoplastic Breast Conservations-The Glasgow Experience.Reoperation Rates in Ductal Carcinoma In Situ vs Invasive Breast Cancer After Wire-Guided Breast-Conserving Surgery.Breast-conserving surgery using an inframammary fold incision technique for breast cancer.Importance of margin width in breast-conserving treatment of early breast cancer.Measuring the quality of sentinel lymph node biopsy (SLNB) for breast cancer: a population-based evaluation.Disease recurrence and survival in patients with multifocal breast cancer: a follow-up study with 7-year results.Predictive and prognostic value of FDG-PET/CT imaging and different response evaluation criteria after primary systemic therapy of breast cancer.Rates of Neoadjuvant Chemotherapy and Oncoplastic Surgery for Breast Cancer Surgery: A French National Survey.
P2860
Q26767039-68A240A4-1D72-4758-A2D3-F3B61416382DQ26773575-047AFB8A-054C-43C8-B86A-A57B0F603935Q26861435-AA932CAD-0E5A-465D-A0EB-EE3DA4D26E8AQ30435780-C2E1E72F-3D51-4254-9C45-61AD6F8720B7Q33591401-887050AC-0209-420F-A22C-0934AE3F57ECQ33848486-D37C9979-DE2A-4C27-8863-DEE7B73380B5Q33972964-425FBC7E-785B-432D-8DAD-A6C08F9E423EQ34457957-B1AC165D-F237-44A2-9D2D-52875AA89DD4Q34655579-07802338-8F73-4875-9D42-5E0BC405BF49Q35078418-721EEBD9-A4F0-41AF-B390-E164E5AA7DD4Q35583779-A9ABFFDB-18D4-4937-85A2-F3D2D5FF8D27Q35903634-D11E042E-94CE-406F-BC4B-3849BA73FEE1Q36202970-C771F35B-E588-451A-BB36-84C8C164F4D5Q36415425-05A21847-5D10-490D-B0D7-B19B49FF857CQ36492482-12AE40F6-162C-4D6B-86C4-03B1CB84C226Q36546612-A53C08EE-F765-4D19-9661-554DC934AAC2Q36576080-789078FC-1A71-4446-8EC3-633F7FCFB21DQ36788252-9119499E-CC46-4636-A53A-323ED6D81733Q36917231-4D1D9D92-19AF-456D-9368-6C3BE3541C24Q36951718-B18E4262-B8F5-4D17-A455-BCE93757CF79Q37353704-422ED0B2-3322-4F1C-A8FF-6DEA278ED8B7Q37389701-73164E22-90C7-43E2-B205-38E4F8F43993Q37657782-E9340A74-FA6D-4A6D-8B46-5143E866A88BQ37845317-BAEA8F61-435D-4ACD-BA64-383C99BF6FACQ37988589-18845DAA-93C4-461E-81FE-1CF61650E01BQ38047337-2D2BA541-CD77-4B31-8D88-3F91FD05423EQ38159974-0A081A99-4ACB-400D-BB87-2EEC43461A47Q38176253-5C157F9E-19AA-4625-B22B-FC2171AA4DCDQ38328673-DC1E87EC-32C9-4F00-A2CA-A22D4DC0D482Q38350939-75A3877A-C990-4DF8-84AD-F63C3072B38EQ38591049-BEAEDB05-36F8-4FBE-B749-A9D5C28C1412Q38974791-EFBDE6A6-5B70-4DAB-9B12-C6E2AC47FD3FQ39070061-1D24D6F1-21D5-4C65-A150-D600A9867AC8Q39077470-AE6DA19B-E08E-47BF-9106-14446933F954Q39666386-5F39B963-F49A-471B-9651-0D2C6487CD9FQ39909294-204AF39B-C680-48F0-B817-30B7BDBD2D9AQ40060519-6F17AAFD-4ACF-4355-B53C-239A1891033BQ40836006-9A19CA1C-D7E4-403C-BD9C-607C8E49EA19Q40852747-2F1A4BF8-AE78-43C0-83F1-4A8E15B1BC57Q41458524-55AAC5F5-FC55-4367-A278-19453FBAD03D
P2860
Locoregional treatment of primary breast cancer: consensus recommendations from an International Expert Panel.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Locoregional treatment of prim ...... an International Expert Panel.
@en
Locoregional treatment of prim ...... an International Expert Panel.
@nl
type
label
Locoregional treatment of prim ...... an International Expert Panel.
@en
Locoregional treatment of prim ...... an International Expert Panel.
@nl
prefLabel
Locoregional treatment of prim ...... an International Expert Panel.
@en
Locoregional treatment of prim ...... an International Expert Panel.
@nl
P2093
P356
P1433
P1476
Locoregional treatment of prim ...... an International Expert Panel.
@en
P2093
Biedenkopf Expert Panel Members
Jay R Harris
Manfred Kaufmann
P2860
P304
P356
10.1002/CNCR.24874
P407
P577
2010-03-01T00:00:00Z